Healthcare provider profile · identity verified

William Joseph Herron, D.O.

Family Practice · IDABEL, OK · NPI 1497753818

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	537	59
Alprazolam	Alprazolam	440	50
Omeprazole	Omeprazole	264	54
Atorvastatin Calcium	Atorvastatin Calcium	218	60
Gabapentin	Gabapentin	198	46
Losartan Potassium	Losartan Potassium	186	42
Hydrochlorothiazide	Hydrochlorothiazide	168	29
Amlodipine Besylate	Amlodipine Besylate	152	41
Levothyroxine Sodium	Levothyroxine Sodium	141	32
Metoprolol Succinate	Metoprolol Succinate	115	34
Lisinopril	Lisinopril	109	34
Furosemide	Furosemide	104	30
Ozempic	Semaglutide	102	15
Meloxicam	Meloxicam	96	23
Potassium Chloride	Potassium Chloride	90	27
Tramadol Hcl	Tramadol Hcl	86	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	81	15
Famotidine	Famotidine	77	15
Zolpidem Tartrate	Zolpidem Tartrate	76	13
Eliquis	Apixaban	75	11
Allopurinol	Allopurinol	73	12
Carvedilol	Carvedilol	73	16
Glimepiride	Glimepiride	72	16
Clopidogrel	Clopidogrel Bisulfate	70	16
Metformin Hcl	Metformin Hcl	69	20
Azithromycin	Azithromycin	68	45
Pregabalin	Pregabalin	66	12
Ibuprofen	Ibuprofen	61	14
Montelukast Sodium	Montelukast Sodium	61	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	59	28
Fluticasone Propionate	Fluticasone Propionate	58	14
Albuterol Sulfate Hfa	Albuterol Sulfate	57	14
Sertraline Hcl	Sertraline Hcl	55	11
Pioglitazone Hcl	Pioglitazone Hcl	54	15
Clonazepam	Clonazepam	53	11
Pantoprazole Sodium	Pantoprazole Sodium	53	13
Simvastatin	Simvastatin	49	13
Donepezil Hcl	Donepezil Hcl	47	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	46	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	42	suppressed
Amoxicillin	Amoxicillin	42	15
Amitriptyline Hcl	Amitriptyline Hcl	41	11
Benazepril Hcl	Benazepril Hcl	41	13
Celecoxib	Celecoxib	41	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	41	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	40	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	40	12
Diazepam	Diazepam	38	suppressed
Duloxetine Hcl	Duloxetine Hcl	36	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	36	suppressed
Fluconazole	Fluconazole	36	18
Levetiracetam	Levetiracetam	36	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	suppressed
Metformin Hcl Er	Metformin Hcl	35	suppressed
Nystatin	Nystatin	34	15
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Ventolin Hfa	Albuterol Sulfate	33	suppressed
Cephalexin	Cephalexin	32	20
Bumetanide	Bumetanide	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Mupirocin	Mupirocin	30	16
Tamsulosin Hcl	Tamsulosin Hcl	30	suppressed
Trazodone Hcl	Trazodone Hcl	29	suppressed
Nateglinide	Nateglinide	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Prednisone	Prednisone	26	suppressed
Vraylar	Cariprazine Hcl	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Finasteride	Finasteride	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	24	suppressed
Baclofen	Baclofen	23	suppressed
Topiramate	Topiramate	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Methylprednisolone	Methylprednisolone	20	18
Sucralfate	Sucralfate	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Naproxen	Naproxen	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Temazepam	Temazepam	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Phenobarbital	Phenobarbital	16	suppressed
Proctofoam-Hc	Hydrocortisone/Pramoxine	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Estradiol	Estradiol	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Levofloxacin	Levofloxacin	13	11
Lorazepam	Lorazepam	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Invega Sustenna	Paliperidone Palmitate	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error